Новая борда о RC

Chemical diversity research institute cdri


Press-center

ChemRar business incubator offers state of the art life science capabilities and services, infrastructure, financing and program management; facilitated access to leading research scientists, institutes, and collaboration networks. www. chemrar.ru About Chemical Diversity Research Institute (CDRI ) Chemical Diversity Research Institute (CDRI Moscow Russia is.DRUGS TECHNOLOGY is the service company which gives vast spectrum of qualitative services for pharmaceutical companies essentially by development modern effective hi-tech and highly profitable generics. For more information: www. drugsformulation.ru « Back.


For more information: www. iihr.ru DRUGS TECHNOLOGY, Ltd. DRUGS TECHNOLOGY, Ltd. is the pharmaceutical development company. DRUGS TECHNOLOGY is created on the basis of. Chemical Diversity Research Institute, Russia. CDRI is  the big scientific and technical complex which is engaged in the combinatory synthesis and.For more information: www. chemrar.ru. Chemical Diversity Research Institute (CDRI ) (CDRI ) - is a contract research organization focused on pre-clinical and clinical R D from target identification to clinical candidate nomination and Proof of Concept in human.ChemRar performs a full cycle of pre-clinical and clinical research of new molecules including screening and identification of the essential biological targets for new molecules, synthesis and research of new molecules as well as full cycle of production.Since 1990 we continue extending quality R D services in CNS, oncology, inflammation, CV and metabolic disease area to the pharma and biotech partners. CDRI s collaboration network encompasses hundreds of scientific institutions and individual research groups in Russia, CIS countries and rest of the.


CDRI sees its mission in enabling discovery and development of innovative therapies for unmet needs utilizing highest expertise and innovation potential of Russian scientists with integrated external R D solutions of Discovery outSourceTM platforms.DRUGS TECHNOLOGY is the service company which gives vast spectrum of qualitative services for pharmaceutical companies essentially by development modern effective hi-tech and highly profitable generics. For more information: www. drugsformulation.ru « Back.CDRI offers internships, graduate and postdoctoral positions to young scientists, attracting returnees with US and European industrial experience thus enhancing the core basic and application sciences and pharmaceutical industrial expertise in Russian Federation.We look forward to working with Novartis scientists in US and Europe and to contribute innovative research to Novartis research programs. About ChemRar Hi-Tech Center ChemRar High Technology Center (ChemRar Moscow, Russia is a unique research complex establishing and supporting biotech and contract research companies.Since 1990 we are providing quality R D services in Virology, CNS, oncology, inflammation, CV and metabolic disease and other areas to our pharma and biotech partners. www. iihr.ru.The mission of the company is to develop and commercialise existing drugs on the basis of novel post-genomic technologies used for treatment of cancer, infectious, cardiovascular and central nervous system (CNS) diseases as well metabolic disorders.ChemRar performs a full cycle of pre-clinical and clinical research of new molecules including screening and identification of the essential biological targets for new molecules, synthesis and research of new molecules as well as full cycle of production.Since 1990 we continue extending quality R D services in CNS, oncology, inflammation, CV and metabolic disease area to the pharma and biotech partners. CDRI s collaboration network encompasses hundreds of scientific institutions and individual research groups in Russia, CIS countries and rest of the.


The Institute has established broad cooperation with the Moscow State University, Moscow Institute of Physics and Technology, D. Mendeleev University of Chemical Technology of Russia and other in science and education fields.Agreement covers the launch of the Oncophage Vaccine, approved in Russia. Lexington, MA and Moscow, Russia, December 19, 2011 - Agenus Inc. (Nasdaq: AGEN a biotechnology company working to develop treatments for cancers and infectious diseases, and NewVac LLC (a subsidiary of ChemRar High Tech.CDRI sees its mission in enabling discovery and development of innovative therapies for unmet needs utilizing highest expertise and innovation potential of Russian scientists with integrated external R D solutions of Discovery outSource platforms.DRUGS TECHNOLOGY is the service company which gives vast spectrum of qualitative services for pharmaceutical companies essentially by development modern effective hi-tech and highly profitable generics. For more information: www. drugsformulation.ru « Back.


Chemical Diversity Research Institute Of Chemrar Announces Starting Of Discovery Collaboration With The Largest Major Pharmaceutical Company On The Russian Market. Nikolay Savchuk, Chairman of CDRI, commented: We are delighted and proud that Novartis recognizes the creativity of our integrated discovery approach based on our.CDRI sees its mission in enabling discovery and development of innovative therapies for unmet needs utilizing highest expertise and innovation potential of Russian scientists with integrated external R D solutions of Discovery outSource platforms.Home Information Partners CHEMRAR Hi-Tech Center ChemRar is a unique pharma and biotechnology conglomerate built in Russian Federation by highly innovative life science R D organizations, discovering, developing and commercializing novel drugs for partners in Russia and worldwide.Since 1990 we are providing quality R D services in Virology, CNS, oncology, inflammation, CV and metabolic disease and other areas to our pharma and biotech partners. www. iihr.ru.Agreement covers the launch of the Oncophage Vaccine, approved in Russia. Lexington, MA and Moscow, Russia, December 19, 2011 - Agenus Inc. (Nasdaq: AGEN a biotechnology company working to develop treatments for cancers and infectious diseases, and NewVac LLC (a subsidiary of ChemRar High Tech.We look forward to working with Novartis scientists in US and Europe and to contribute innovative research to Novartis research programs. About ChemRar Hi-Tech Center ChemRar High Technology Center (ChemRar Moscow, Russia is a unique research complex establishing and supporting biotech and contract research companies.DRUGS TECHNOLOGY is the service company which gives vast spectrum of qualitative services for pharmaceutical companies essentially by development modern effective hi-tech and highly profitable generics. For more information: www. drugsformulation.ru « Back.The mission of the company is to develop and commercialise existing drugs on the basis of novel post-genomic technologies used for treatment of cancer, infectious, cardiovascular and central nervous system (CNS) diseases as well metabolic disorders.


 

Читайте еще: